treatment

The medicine is one of the few to win regulatory approval as a treatment for the disease, but has fallen out of favor with the health authority.

Chloroquine and hydroxycloroquine got the Food and Drug Administration's go-ahead to be put in the nation's strategic storehouses. But the drugs haven't been approved to treat coronavirus patients.

They're testing some drugs developed for other diseases. And they're offering supportive care — doing whatever's possible to keep vital organ systems functioning.

Learning strategies to deal with chronic pain can be an effective way to stay off addictive medicines, says the head of the Mayo Clinic's pain rehab center. But insurance doesn't always cover it.